TrialJournal of the peripheral nervous system : JPNS2020

An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study.

Eduardo Nobile-Orazio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.